Recent spikes in Dartmouth’s application numbers from a test-optional policy have plateaued in the current cycle.

The company is working with the U.S. regulator to move forward with an updated application, adding a decision is expected in ...

On February 3, 2026, President Trump signed H.R.7148, the Consolidated Appropriations Act, 2026, into law. Section 6703 of the Act, ...

NASA’s internship programs reportedly give students a chance to experience real space science. You don’t need to be a ...

If they build it, would riders come along on the “TC to KC” line for a long weekend, with thoughts of Kansas City barbeque in ...

Gov. Jim Pillen’s administration, facing scrutiny for a no-bid emergency contract with a lobbyist to whom he steered more ...

Zanzalintinib is an investigational oral agent that inhibits tyrosine kinase receptors associated with cancer growth, including TYRO3, VEGF, MET, AXL, and MER.

We helped usher in the modern era of AI in NGA. I became the agency’s first chief AI officer. I set the agency strategy for ...

GT Bio's CEO Michael Breen said he's seen "encouraging trends" in ongoing AML Phase I trials that could validate the platform's efficacy as the company moves into solid tumors. The firm's leadership ...

Trump created an illegal ‘fast lane’ for wealthy foreigners at the expense of qualified immigrants who followed the rules, ...

The FDA rejected AstraZeneca's subcutaneous Saphnelo application, delaying U.S. approval until 2026, despite positive ...

With hundreds of thousands applying for just tens of thousands of spots — generating millions in fees — critics say the system disproportionately affects learners from low-income and rural households.